Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (751-760 of 1,095) with videos related to

Pageof 110
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 9, 2023
A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019Anthony Nardone, Lina Nerlander, Erika Duffell, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
Scientific Reports|April 20, 2026
HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter studyAna Fuentes López, Ariadna Rando Segura, Raquel Carracedo, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.
Plos One|December 10, 2015
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV InfectionTarik Asselah, Stefan Zeuzem, Vicente Soriano, et al.
World Journal of Clinical Oncology|December 15, 2021
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case seriesSebastiano Buti, Melissa Bersanelli, Francesco Massari, et al.
Viruses|February 26, 2022
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and VariabilityBeatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Scientific Reports|February 28, 2024
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective studyLucia Fratino, Jerry Polesel, Emilio Francesco Giunta, et al.
Pageof 110

Showing results (751-760 of 1,095) with videos related to

Sort By:
Pageof 110
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 9, 2023
A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019Anthony Nardone, Lina Nerlander, Erika Duffell, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
Scientific Reports|April 20, 2026
HCV RNA quantification using the Cobas Plasma Separation Card as an alternative to EDTA plasma: a prospective multicenter studyAna Fuentes López, Ariadna Rando Segura, Raquel Carracedo, et al.
Alimentary Pharmacology & Therapeutics|April 21, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European StudyAdriana Palom, Elisabetta Degasperi, Barbara Coco, et al.
Plos One|December 10, 2015
ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV InfectionTarik Asselah, Stefan Zeuzem, Vicente Soriano, et al.
World Journal of Clinical Oncology|December 15, 2021
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case seriesSebastiano Buti, Melissa Bersanelli, Francesco Massari, et al.
Viruses|February 26, 2022
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and VariabilityBeatriz Pacin-Ruiz, María Francesca Cortese, David Tabernero, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Communications Medicine|December 14, 2023
Community-based screening enhances hepatitis B virus linkage to care among West African migrants in SpainCamila A Picchio, Daniel K Nomah, Ariadna Rando-Segura, et al.
Scientific Reports|February 28, 2024
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective studyLucia Fratino, Jerry Polesel, Emilio Francesco Giunta, et al.
Pageof 110